Bharat Biotech to start human trials for first indigenous Covid-19 vaccine
India-based biotechnology company Bharat Biotech has secured regulatory approval from the Drug Controller General of India (DCGI) to advance its Covid-19 vaccine candidate, Covaxin, into human clinical trials.